{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:25:18Z","timestamp":1786969518703,"version":"build-2736575974"},"reference-count":66,"publisher":"American Chemical Society (ACS)","issue":"16","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of this study is to investigate active targeting of residual melanoma cells. Melanoma is the most aggressive form of skin cancer for which the conventional therapies often fail to target post-surgical residual cells owing to challenges like chemoresistance, early metastasis, and recurrence. To mitigate the following issues, we repurposed Dasatinib (DAS), an antineoplastic drug approved for chronic myeloid leukaemia, and evaluated its potential in melanoma treatment through a safe, biomacromolecule-based topical delivery system. DAS-loaded human serum albumin nanoparticles (DNPs) were optimised via Box-Behnken design and incorporated into a hydrogel for localised delivery. The DNPs had a particle size of 125.6 \u00b1 1.58 nm with a polydispersity index of 0.242 \u00b1 0.008 and a zeta potential of \u201314.28 \u00b1 0.22 mV. ATR-FTIR, PXRD, and DSC analyses demonstrated amorphisation of the drug in DNPs devoid of any chemical interactions. The loading and entrapment efficiencies of DAS in DNPs were estimated to be 7.49 \u00b1 0.28 and 89.80 \u00b1 1.52%, respectively. In vitro assays such as the MTT assay, scratch assay, transwell-based invasive assays, cell cycle assay, and 3D tumoroid-based assays demonstrated superior cytotoxic, anti-invasion, and antimigration properties of DNPs. Mechanistic studies demonstrated that DNPs induced apoptosis via caspase-7 upregulation and downregulation of PI3K, p-mTOR, VEGFR, and EGFR. Dermatokinetic analysis of DNPs-entrapped hydrogel confirmed DNPs accumulation in the epidermal and dermal layers near residual melanoma cells, highlighting their therapeutic potential in the management of residual disease.<\/jats:p>","DOI":"10.1021\/acsabm.6c00772","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:19:23Z","timestamp":1785849563000},"page":"7512-7536","source":"Crossref","is-referenced-by-count":0,"title":["Dasatinib-Loaded Human Serum Albumin Nanoparticle-Impregnated Hydrogel for Localised Eradication of Residual Melanoma: Integrated\n                    <i>In Silico<\/i>\n                    , 3D Spheroid, and Dermatokinetic Evaluation"],"prefix":"10.1021","volume":"9","author":[{"given":"Ganesh","family":"Vambhurkar","sequence":"first","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Famta","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Shah","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Sharma","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika","family":"Puri","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etikala","family":"Amulya","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Wagh","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Sikder","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin Pal","family":"Kalia","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-4363","authenticated-orcid":true,"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research (NIPER) , , , ,","place":["Hyderabad, Telangana, India, 500037"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"3","key":"2026081707170178400_cit1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"2026081707170178400_cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2026.103167","article-title":"Biomaterial-Based Strategies for Postoperative Residual Tumors: From Margin Clearance to Immune Control and Tissue Repair","volume":"38","author":"Zou","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"3","key":"2026081707170178400_cit3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jso.24111","article-title":"The Importance of Surgical Margins in Melanoma","volume":"113","author":"Ethun","year":"2016","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"2026081707170178400_cit4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/sonc.2002.35238","article-title":"Metastatic Melanoma: Chemotherapy","volume":"29","author":"Bajetta","year":"2002","journal-title":"Semin. Oncol."},{"key":"2026081707170178400_cit5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1479-5876-6-53","article-title":"Preclinical Evaluation of Dasatinib, a Potent Src Kinase Inhibitor, in Melanoma Cell Lines","volume":"6","author":"Eustace","year":"2008","journal-title":"J. Transl. Med."},{"key":"2026081707170178400_cit6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2017.01.029","article-title":"Potential Therapeutic Targets of Epithelial\u2013Mesenchymal Transition in Melanoma","volume":"391","author":"Pearlman","year":"2017","journal-title":"Cancer Lett."},{"issue":"47","key":"2026081707170178400_cit7","doi-asserted-by":"publisher","first-page":"52402","DOI":"10.1021\/acsami.0c15983","article-title":"Targeting Tumor-Associated Macrophages by MMP2-Sensitive Apoptotic Body-Mimicking Nanoparticles","volume":"12","author":"Liu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026081707170178400_cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.sciaf.2025.e03101","article-title":"Advances in Nanoparticles as Drug Delivery Systems: A Review","volume":"30","author":"Akomolafe","year":"2025","journal-title":"Sci. African"},{"issue":"16","key":"2026081707170178400_cit9","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3390\/polym15163354","article-title":"Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective","volume":"15","author":"Li","year":"2023","journal-title":"Polymers (Basel)"},{"issue":"17","key":"2026081707170178400_cit10","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.3390\/ijms26178743","article-title":"Regulatory Mechanisms of SPARC Overexpression in Melanoma Progression","volume":"26","author":"Vinyals","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"2026081707170178400_cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123784","article-title":"Dasatinib Loaded Mucoadhesive Lecithin-Chitosan Hybrid Nanoparticles for Its Augmented Oral Delivery, in-Vitro Efficacy and Safety","volume":"651","author":"Mehandole","year":"2024","journal-title":"Int. J. Pharm."},{"key":"2026081707170178400_cit12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/9783527831708.ch13","article-title":"ICH Q2(R2): Validation of Analytical Procedures","author":"Ermer","year":"2025","journal-title":"Method Validation in Pharmaceutical Analysis: A Guide to Best Practice, Third Edition"},{"key":"2026081707170178400_cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142185","article-title":"Development and Evaluation of Nilotinib-Loaded Bovine Serum Albumin Nanoparticles: In-Vitro and in-Silico Insights","volume":"308","author":"Shaikh","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"2026081707170178400_cit14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/03639045.2025.2509861","article-title":"Combating Breast Cancer-Associated Metastasis Using Paclitaxel and Tranilast-Loaded Human Serum Albumin Nanoparticles","volume":"51","author":"Jain","year":"2025","journal-title":"Drug Dev. Ind. Pharm."},{"key":"2026081707170178400_cit15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejpb.2022.09.024","article-title":"Quality by Design Steered Development of Niclosamide Loaded Liposomal Thermogel for Melanoma: In Vitro and Ex Vivo Evaluation","volume":"180","author":"Shah","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"2026081707170178400_cit16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/gels9110896","article-title":"Preparation and Optimization of Bovine Serum Albumin Nanoparticles as a Promising Gelling System for Enhanced Nasal Drug Administration","volume":"9","author":"Mardikasari","year":"2023","journal-title":"Gels"},{"issue":"7","key":"2026081707170178400_cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17732","article-title":"Albumin-Coated Copper Nanoparticles for Photothermal Cancer Therapy: Synthesis and in Vitro Characterization","volume":"9","author":"Amatya","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"2026081707170178400_cit18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/ijms20030591","article-title":"Dasatinib\/HP-\u03b2-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders","volume":"20","author":"Cutrignelli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"2026081707170178400_cit19","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1021\/acsomega.1c06753","article-title":"Stable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties","volume":"7","author":"Saladi","year":"2022","journal-title":"ACS Omega"},{"issue":"6","key":"2026081707170178400_cit20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/09205063.2024.2427489","article-title":"Development, Optimization, and Characterization of Eudragit-Based Nanoparticles for Dasatinib Delivery","volume":"36","author":"G","year":"2025","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"2","key":"2026081707170178400_cit21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17425247.2017.1264386","article-title":"Solid Lipid Nanoparticles and Nanostructured Lipid Carrier-Based Nanotherapeutics in Treatment of Psoriasis: A Comparative Study","volume":"14","author":"Arora","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"6","key":"2026081707170178400_cit22","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s13346-024-01732-5","article-title":"Topical Delivery of Baricitinib-Impregnated Nanoemulgel: A Promising Platform for Inhibition of JAK -STAT Pathway for the Effective Management of Atopic Dermatitis","volume":"15","author":"Nene","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"2026081707170178400_cit23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s13346-024-01565-2","article-title":"High Mobility Group Box 1 Cytokine Targeted Topical Delivery of Resveratrol Embedded Nanoemulgel for the Management of Atopic Dermatitis","volume":"15","author":"Nene","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"2026081707170178400_cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105252","article-title":"Quality by Design Galvanized Development of Resveratrol Loaded PLGA Nanoparticles: In Vitro and Ex Vivo Evaluation for the Non-Invasive Treatment of Metastatic Melanoma","volume":"91","author":"Vambhurkar","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"2026081707170178400_cit25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2024.104290","article-title":"Photothermal Therapy Improves the Efficacy of Topical Immunotherapy against Melanoma","volume":"49","author":"Shi","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"1","key":"2026081707170178400_cit26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1755-1536-6-6","article-title":"Secreted Protein Acidic and Rich in Cysteine (SPARC) Is Upregulated by Transforming Growth Factor (TGF)-\u03b2 and Is Required for TGF-\u03b2-Induced Hydrogen Peroxide Production in Fibroblasts","volume":"6","author":"Shibata","year":"2013","journal-title":"Fibrogenes. Tissue Repair"},{"key":"2026081707170178400_cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136090","article-title":"Bovine Serum Albumin-Bound Homologous Targeted Nanoparticles for Breast Cancer Combinatorial Therapy","volume":"281","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"2026081707170178400_cit28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3892\/mmr.2019.10896","article-title":"Phellinus Gilvus-Derived Protocatechualdehyde Induces G0\/G1 Phase Arrest and Apoptosis in Murine B16-F10 Cells","volume":"21","author":"Zhong","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"2026081707170178400_cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105399","article-title":"Raloxifene Loaded D-\u03b1-Tocopherol Polyethylene Glycol 1000 Succinate Stabilized Poly (\u03b5-Caprolactone) Nanoparticles Augmented Drug Delivery and Apoptosis in Breast Cancer Cells","volume":"92","author":"Mourya","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"96","key":"2026081707170178400_cit30","doi-asserted-by":"publisher","first-page":"93590","DOI":"10.1039\/c6ra18879f","article-title":"The Oleanolic Acid Derivative, 3-: O -Succinyl-28- O -Benzyl Oleanolate, Induces Apoptosis in B16-F10 Melanoma Cells via the Mitochondrial Apoptotic Pathway","volume":"6","author":"Reyes-Zurita","year":"2016","journal-title":"RSC Adv."},{"issue":"5","key":"2026081707170178400_cit31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.31557\/APJCP.2020.21.5.1275","article-title":"Ethanol Extract of Hizikia Fusiforme Induces Apoptosis in B16F10 Mouse Melanoma Cells through ROS-Dependent Inhibition of the PI3K\/Akt Signaling Pathway","volume":"21","author":"Park","year":"2020","journal-title":"Asian Pacific J. Cancer Prev."},{"key":"2026081707170178400_cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123787","article-title":"Targeted Delivery and Apoptosis Induction of CDK-4\/6 Inhibitor Loaded Folic Acid Decorated Lipid-Polymer Hybrid Nanoparticles in Breast Cancer Cells","volume":"651","author":"Rajana","year":"2024","journal-title":"Int. J. Pharm."},{"key":"2026081707170178400_cit33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.biopha.2014.12.011","article-title":"Lobaplatin Arrests Cell Cycle Progression, Induces Apoptosis and Impairs Migration and Invasion in B16-F10 Melanoma Cell Line in Vitro","volume":"69","author":"Yang","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"2026081707170178400_cit34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12668-025-01935-1","article-title":"Establishment and Evaluation of Paclitaxel and Simvastatin-Laden Nanofibers for Post-Surgical Tumor Recurrence in Breast Cancer","volume":"15","author":"Famta","year":"2025","journal-title":"Bionanoscience"},{"issue":"4","key":"2026081707170178400_cit35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"2026081707170178400_cit36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jconrel.2020.04.025","article-title":"Colorectal Cancer Triple Co-Culture Spheroid Model to Assess the Biocompatibility and Anticancer Properties of Polymeric Nanoparticles","volume":"323","author":"Bauleth-Ramos","year":"2020","journal-title":"J. Control. Release"},{"issue":"5","key":"2026081707170178400_cit37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.15388\/NA.2019.5.9","article-title":"Modeling the Uptake of Fluorescent Molecules into 3D Cellular Spheroids","volume":"24","author":"Astrauskas","year":"2019","journal-title":"Nonlinear Anal. Model. Control"},{"key":"2026081707170178400_cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149411","article-title":"Nanoparticle-Enhanced Delivery of Resveratrol for Targeted Therapy of Glioblastoma: Modulating the Akt\/GSK-3\u03b2\/NF-KB Pathway in C6 Glioma Cells","volume":"1848","author":"Singh","year":"2025","journal-title":"Brain Res."},{"issue":"8","key":"2026081707170178400_cit39","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.3390\/ijms22084096","article-title":"Decursinol Angelate Arrest Melanoma Cell Proliferation by Initiating Cell Death and Tumor Shrinkage via Induction of Apoptosis","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"2026081707170178400_cit40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s13205-021-02841-5","article-title":"Brucine-Loaded Transliposomes Nanogel for Topical Delivery in Skin Cancer: Statistical Optimization, in Vitro and Dermatokinetic Evaluation","volume":"11","author":"Alhakamy","year":"2021","journal-title":"3 Biotech"},{"issue":"7","key":"2026081707170178400_cit41","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1158\/1541-7786.MCR-20-1040","article-title":"Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3\/MITF\/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit","volume":"19","author":"Sabbah","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"13_Supplement","key":"2026081707170178400_cit42","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1158\/1538-7445.am2019-2085","article-title":"Abstract 2085: Treatment of Human Melanoma Cells with Dasatinib Requires Inactivation of Both MTOR and MAPK Pathways to Achieve High Cell Eradication Efficacy","volume":"79","author":"Vachtenheim","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"2026081707170178400_cit43","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.leukres.2012.07.013","article-title":"Dasatinib Inhibits Leukaemic Cell Survival by Decreasing PRH\/Hhex Phosphorylation Resulting in Increased Repression of VEGF Signalling Genes","volume":"36","author":"Noy","year":"2012","journal-title":"Leuk. Res."},{"issue":"7","key":"2026081707170178400_cit44","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.21873\/anticanres.15827","article-title":"Targeted Treatment of HPV16-Positive and -Negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression","volume":"42","author":"Huber","year":"2022","journal-title":"Anticancer Res."},{"issue":"7","key":"2026081707170178400_cit45","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/abbs\/gmab061","article-title":"Dasatinib Inhibits Proliferation of Liver Cancer Cells, but Activation of Akt\/MTOR Compromises Dasatinib as a Cancer Drug","volume":"53","author":"Liu","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)."},{"key":"2026081707170178400_cit46","doi-asserted-by":"crossref","unstructured":"Lozano Gil, J. M.; Rodr\u00edguez-Ruiz, L.; Palacios, M.; Peral, J.; Navarro, S.; Fuster, J. L.; Bel\u00e9ndez, C.; J\u00e9rez, A.; Murillo-Sanju\u00e1n, L.; D\u00edaz-de-Heredia, C.; L\u00f3pez-de-Hontanar, G.; Zubicaray, J.; Sevilla, J.; Ferrer-Mar\u00edn, F.; Sepulcre, M. P.; Cayuela, M. L.; Garc\u00eda-Moreno, D.; Mart\u00ednez-L\u00f3pez, A.; Tyrkalska, S. D.; Mulero, V.\n          Inhibition of NLRP1 Inflammasome Activation by Tyrosine Kinase Inhibitors Restores Erythropoiesis in Diamond-Blackfan Anemia Syndrome, 2025.","DOI":"10.1101\/2025.02.20.639294"},{"issue":"1","key":"2026081707170178400_cit47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12943-015-0468-0","article-title":"Dasatinib Blocks Transcriptional and Promigratory Responses to Transforming Growth Factor-Beta in Pancreatic Adenocarcinoma Cells through Inhibition of Smad Signalling: Implications for in Vivo Mode of Action","volume":"14","author":"Bartscht","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"2026081707170178400_cit48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41420-020-0270-7","article-title":"Inhibition of IKK\u03b2\/NF-\u039aB Signaling Pathway to Improve Dasatinib Efficacy in Suppression of Cisplatin-Resistant Head and Neck Squamous Cell Carcinoma","volume":"6","author":"Yang","year":"2020","journal-title":"Cell Death Discov."},{"issue":"4","key":"2026081707170178400_cit49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/cancers11040548","article-title":"Dasatinib Treatment Increases Sensitivity to C-Met Inhibition in Triple-Negative Breast Cancer Cells","volume":"11","author":"Gaule","year":"2019","journal-title":"Cancers (Basel)."},{"issue":"11","key":"2026081707170178400_cit50","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1158\/1541-7786.MCR-08-0169","article-title":"Inhibition of Src Family Kinases with Dasatinib Blocks Migration and Invasion of Human Melanoma Cells","volume":"6","author":"Buettner","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"2026081707170178400_cit51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtocrr.2022.100278","article-title":"YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs","volume":"3","author":"Minari","year":"2022","journal-title":"JTO Clin. Res. Reports"},{"issue":"1","key":"2026081707170178400_cit52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12860-018-0180-1","article-title":"Post-Treatment de-Phosphorylation of P53 Correlates with Dasatinib Responsiveness in Malignant Melanoma","volume":"19","author":"Skoko","year":"2018","journal-title":"BMC Cell Biol."},{"key":"2026081707170178400_cit53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.556532","article-title":"Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"2026081707170178400_cit54","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1596\/neo.12300","article-title":"Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells","volume":"14","author":"Lin","year":"2012","journal-title":"Neoplasia (United States)"},{"issue":"1","key":"2026081707170178400_cit55","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12885-020-07134-3","article-title":"Transcriptomic Insight into Salinomycin Mechanisms in Breast Cancer Cell Lines: Synergistic Effects with Dasatinib and Induction of Estrogen Receptor \u03b2","volume":"20","author":"Bellat","year":"2020","journal-title":"BMC Cancer"},{"issue":"15_suppl","key":"2026081707170178400_cit56","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1200\/jco.2009.27.15_suppl.1084","article-title":"Effect of Dasatinib on the Activity of Trastuzumab in HER2-Overexpressing Breast Cancer Cells","volume":"27","author":"Seoane","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"2026081707170178400_cit57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006619","article-title":"PD-1 Blockade in Combination with Dasatinib Potentiates Induction of Anti-Acute Lymphocytic Leukemia Immunity","volume":"11","author":"Koller","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"2026081707170178400_cit58","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","article-title":"Dasatinib: A Potent SRC Inhibitor in Clinical Development for the Treatment of Solid Tumors","volume":"36","author":"Araujo","year":"2010","journal-title":"Cancer Treat. Rev."},{"issue":"12","key":"2026081707170178400_cit59","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.exphem.2009.09.007","article-title":"Dasatinib Inhibits the Secretion of TNF-\u03b1 Following TLR Stimulation in Vitro and in Vivo","volume":"37","author":"Fraser","year":"2009","journal-title":"Exp. Hematol."},{"issue":"4","key":"2026081707170178400_cit60","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00405-013-2394-3","article-title":"Antitumor Effects of Dasatinib on Laryngeal Squamous Cell Carcinoma in Vivo and in Vitro","volume":"270","author":"Song","year":"2013","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"2026081707170178400_cit61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejpb.2023.07.008","article-title":"Quality by Design Endorsed Fabrication of Ibrutinib-Loaded Human Serum Albumin Nanoparticles for the Management of Leukemia","volume":"190","author":"Famta","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"2026081707170178400_cit62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0378-5173(03)00134-0","article-title":"Optimization of the Preparation Process for Human Serum Albumin (HSA) Nanoparticles","volume":"257","author":"Langer","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"1","key":"2026081707170178400_cit63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijpharm.2017.11.024","article-title":"Rational Design of Polysorbate 80 Stabilized Human Serum Albumin Nanoparticles Tailored for High Drug Loading and Entrapment of Irinotecan","volume":"536","author":"Taneja","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"3","key":"2026081707170178400_cit64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.22159\/ijap.2024v16i3.50434","article-title":"Development and Optimization of Super Saturable Self-Nano Emulsifying Drug Delivery System for Dasatinib By Design of Experiment","volume":"16","author":"Rajinikanth","year":"2024","journal-title":"Int. J. Appl. Pharm."},{"issue":"14","key":"2026081707170178400_cit65","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700181","article-title":"Self-Targeting, Immune Transparent Plasma Protein Coated Nanocomplex for Noninvasive Photothermal Anticancer Therapy","volume":"6","author":"Mi","year":"2017","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"2026081707170178400_cit66","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-06-3469","article-title":"Dasatinib Inhibits Migration and Invasion in Diverse Human Sarcoma Cell Lines and Induces Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival","volume":"67","author":"Shor","year":"2007","journal-title":"Cancer Res."}],"container-title":["ACS Applied Bio Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsabm.6c00772","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article-pdf\/9\/16\/7512\/66333902\/mt-2026-00772d.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article-pdf\/9\/16\/7512\/66333902\/mt-2026-00772d.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:31:57Z","timestamp":1786966317000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aabmcb\/article\/9\/16\/7512\/5236967\/Dasatinib-Loaded-Human-Serum-Albumin-Nanoparticle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":66,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,7,29]]},"published-print":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1021\/acsabm.6c00772","relation":{},"ISSN":["2576-6422"],"issn-type":[{"value":"2576-6422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}